Neutrogena and Aveeno were key drivers of Johnson & Johnson’s Consumer division results in the second quarter, potentially reflecting continued strong consumer response to launches designated as ‘Rapid’ solutions or positioned with one-week results claims.
J&J Consumer division execs highlighted the company’s fast-acting skin-care technology in an investor day presentation in May, pointing to the...


